Glue degraders are small molecules that bring a target protein into proximity of a ligase protein, leading to the degradation of the target protein via the natural protein recycling machinery present in every cell. Compared to other types of drugs, glue degraders have vast advantages: they can target any protein in the cell, they are exceptionally selective against a given target protein, and their effect is catalytic, meaning once a protein is degraded, they move on to the next protein and repeat the cycle.

The most versatile modality

Most drugs are designed to block one specific function of a disease-causing protein. But over 80% of human proteins are not accessible via this approach and are generally considered “undruggable”. Although many important drivers of disease have been known for decades, they are simply out of reach. Glue degraders circumvent this limitation as they do not rely on the requirements of traditional pharmacology. The right glue degrader can attack any given target protein in the cell and lead to its removal.

Target
protein
Proteasome
Degraded
target protein

We are pioneers

As exciting as glue degraders are, they are very difficult to find. Before Proxygen was founded, there was no systematic way of identifying glue degraders. We have built and are constantly developing a highly versatile glue degrader identification platform, deploying the right tools and technologies for a given target, enabling us to quickly find glue degraders against proteins of high medical relevance.

Features

“These are trailblazing times for the pharmacology of glues, with the Proxygen team leading at the new frontier of scientific discovery. It feels like a thrilling horseback gallop, the wind in your hair as you explore new territories and vistas at exhilarating speed.”

Giulio Superti-Furga